Post
FivepHusion collaborates with Treehill, Syneos for Deflexifol
FivepHusion has collaborated with Treehill Partners and Syneos Health to strategically progress development and commercialisation of its chemotherapeutic formulation Deflexifol …
Novavax receives positive opinion from CHMP for full MA of Covid vaccine
Novavax has received positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for full …
AstraZeneca’s Ultomiris receives Japanese approval for NMOSD
AstraZeneca has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its Ultomiris (ravulizumab) to prevent …
Why is the healthcare industry hesitant to join the metaverse?
The Covid-19 pandemic pushed the healthcare industry toward rapid digitalisation, with the rise of telehealth, telepresence systems, remote diagnostics, predictive …
Who’s acquiring who? Orphan designated drugs M&A activity in the pharmaceutical industry decreased by 23% in Q1 2023
Analysis of the key themes driving M&A activity reveals that orphan designated drugs accounted for 20 pharmaceutical deals announced in …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Who’s acquiring who? Virtual care M&A activity in the pharmaceutical industry increased by 100% in Q1 2023
Analysis of the key themes driving M&A activity reveals that virtual care accounted for 6 pharmaceutical deals announced in Q1 …
FDA awards full approval to Paxlovid amidst hazy coverage plans
After earning multimillion dollar revenues while being an authorised preferred treatment for Covid-19, the US Food and Drug Administration (FDA) …
Immuno-oncology market set to grow in billions, but access concerns remain
The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in …
Touchlight boosts DNA manufacturing capacity with latest expansion
Enzymatic DNA production company Touchlight have augmented its DNA production capabilities with a newly announced expansion to its London facilities. …
Beta Bionics’ automated insulin delivery system picks up manufacturing partner
Chronic disease tech company Convatec Group has partnered with Beta Bionics to manufacture the insulin delivery system iLet Bionic Pancrease. According …
Illegal online pharmacies gain traction as regulators lag behind
Amidst an insulin pricing crisis and consistent shortages of drugs ranging from Teva’s attention deficit hyperactivity disorder (ADHD) medication Adderall …
BSM supplies key component of Krystal Biotech’s DEB gene therapy
Berkshire Sterile Manufacturing (BSM) has supplied an excipient gel, a key component of Krystal Biotech’s gene therapy VYJUVEK, for dystrophic …
After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the …
Excitement associated with FDA approval of Rinvoq in Crohn’s disease
On 18 May 2023, the FDA announced the approval of Rinvoq (upadacitinib), AbbVie’s Janus kinase inhibitor (JAKi), to treat adults …
Daiichi Sankyo receives Japan’s MHLW approval for VANFLYTA
Daiichi Sankyo has received approval from Japan’s ministry of health, labour and welfare (MHLW) for VANFLYTA (quizartinib) to treat acute …